JB Chemicals non-committal on dividend
JB Mody, CMD of JB Chemicals and Pharma says the company will lose 30 per cent of top line after the sale of its OTC brands in Russia and CIS countries to J&J subsidiary. The company will continue to look after the shareholders’ interests, the CMD assured.
